Beta-blocker use is associated with reduced mortality and improved long-term survival in patients with sepsis-induced myocardial injury.
Does beta-blocker use reduce mortality and improve long-term survival in patients with sepsis-induced myocardial injury?
Beta-blocker use may improve survival in patients with sepsis-induced myocardial injury, highlighting a potential therapeutic strategy that requires prospective validation.
Tasa de eventos absoluta: 0% vs 0%
Beta-blocker use is associated with reduced mortality and better long-term survival in SIMI patients, requiring prospective validation.
Wu et al. (Sun,) reported a other. Beta-blocker use is associated with reduced mortality and improved long-term survival in patients with sepsis-induced myocardial injury.